BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 2459201)

  • 1. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
    Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
    J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP; Bach FH; Wu SK
    J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple regions of HLA-DR beta 1 chains determine polymorphic epitopes recognized by monoclonal antibodies.
    Alber CA; Watts R; Klohe EP; Drover S; Marshall WH; Radka SF; Karr RW
    J Immunol; 1989 Oct; 143(7):2248-55. PubMed ID: 2476501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells.
    Kawai J; Ando A; Sato T; Nakatsuji T; Tsuji K; Inoko H
    J Immunol; 1989 Jan; 142(1):312-7. PubMed ID: 2462589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional difference between HLA-DR and HLA-DQ molecules in mixed lymphocyte reaction].
    Fujisawa K
    Fukuoka Igaku Zasshi; 1989 Jan; 80(1):49-59. PubMed ID: 2524437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-D region alpha-chain monoclonal antibodies: cross-reaction between an anti-DP alpha-chain antibody and smooth muscle.
    Thomas A; Lindsay J; Wilkinson M; Bodmer J
    J Pathol; 1988 Apr; 154(4):353-63. PubMed ID: 2455029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High precursor frequency of human T cells reactive to HLA-DQ molecules expressed on mouse L cell transfectants.
    Fujisawa K; Kamikawaji N; Yasunami M; Kimura A; Nishimura Y; Sasazuki T
    Eur J Immunol; 1991 Oct; 21(10):2341-7. PubMed ID: 1717282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
    Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
    Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of an HLA-DR-specific monoclonal antibody produced by using human-mouse transfectant cells.
    Madrigal JA; Ikeda H; Marsh SG; Heyes JM; Kennedy LJ; Trowsdale J; Bodmer JG
    J Immunol; 1989 Dec; 143(12):4084-9. PubMed ID: 2480386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical analysis of a cell transfected with an HLA-DR gene reveals a new alloantigenic specificity within HLA-DRw52.
    Tosi R; Tanigaki N; De Préval C; Gorski J; Mach B
    Eur J Immunol; 1986 Dec; 16(12):1603-8. PubMed ID: 2434336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A newly characterized HLA-DP beta-chain allele. Evidence for DP beta heterogeneity within the DPw4 specificity.
    Lair B; Alber C; Yu WY; Watts R; Bahl M; Karr RW
    J Immunol; 1988 Aug; 141(4):1353-7. PubMed ID: 2456351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
    Diedrichs M; Schendel DJ
    J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete sequence of the HLA DQ alpha and DQ beta cDNA from a DR5/DQw3 cell line.
    Schiffenbauer J; Didier DK; Klearman M; Rice K; Shuman S; Tieber VL; Kittlesen DJ; Schwartz BD
    J Immunol; 1987 Jul; 139(1):228-33. PubMed ID: 3584986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
    Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
    Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis.
    Yoshino T; Cao L; Nishiuchi R; Matsuo Y; Yamadori I; Kondo E; Teramoto N; Hayashi K; Takahashi K; Kamikawaji N
    Eur J Immunol; 1995 Aug; 25(8):2190-4. PubMed ID: 7545111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.